{"id":"W3181256475","doi":"10.1136/jitc-2021-002552","title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Society for Immunotherapy of Cancer; Bladder Cancer Advocacy Network","keywords":"Medicine; Immunotherapy; Urothelial cancer; Guideline; Bladder cancer; Cancer; Atezolizumab; Intensive care medicine; Oncology; Cancer immunotherapy; Internal medicine; Pembrolizumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007174436,0.001013605,0.001610942,0.003853192,0.00136436,0.00212202,0.003668896,0.00787011,0.00689584],"category_scores_gemma":[0.02218438,0.0007305771,0.003129455,0.003785057,0.001081328,0.001436544,0.002216672,0.008557389,0.005923615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005211862,"about_ca_system_score_gemma":0.0222445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02500935,"about_ca_topic_score_gemma":0.04815789,"domain_scores_codex":[0.9915258,0.003361662,0.001779876,0.0003106786,0.00249303,0.0005289632],"domain_scores_gemma":[0.9834946,0.004011718,0.001669741,0.0002905861,0.00962595,0.0009074518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004638835,0.0001109843,0.0005930216,0.003365801,0.00008283028,0.000212107,0.0001791747,0.0007361238,0.0004613228,0.003365642,0.9095125,0.08133402],"study_design_scores_gemma":[0.0001840388,0.00008768751,0.001778231,0.01113254,0.000189461,0.0007098923,0.0001117752,0.0005170231,0.000278186,0.00371021,0.9812617,0.00003921119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.003709558,0.1619868,0.03522032,0.4617437,0.03420283,0.01626844,0.02328925,0.001577826,0.2620012],"genre_scores_gemma":[0.03203793,0.2552556,0.184397,0.3411735,0.00898933,0.02194834,0.07283872,0.0005322733,0.08282732],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02500935,"threshold_uncertainty_score":0.0497275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06021223239992654,"score_gpt":0.4578172749400112,"score_spread":0.3976050425400847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}